Top Story

FDA grants orphan drug status to lenabasum for dermatomyositis

July 20, 2018

ACR ‘deeply concerned’ over CY 2019 physician fee schedule proposed cuts

July 20, 2018
The American College of Rheumatology has expressed deep concern regarding a CMS calendar year 2019 physician fee schedule proposed rule, which it says would cut…
FDA News

Gottlieb: FDA will not 'play regulatory whack-a-mole' with those delaying biosimilar competition

July 19, 2018
In a statement introducing an action plan aimed at promoting competition across the drug market for biosimilar and biologic products, FDA Commissioner Scott
In the Journals

Only 30% of RA patients report dietary supplement use to physicians

July 19, 2018
Although nearly half of patients with RA use natural dietary supplements, just 30% of these patients inform their physician about their use, according to findings…
More Headlines »

But How Similar is it? What You Need to Know and What to Tell Your Patients about Biosimilars

This activity is supported by an educational grant from Pfizer, Inc.

As more biosimilars are approved for use in the United States, all members of the multidisciplinary care team will…
More »
GI Bookshelf

Chapter 14: Nutrition In The Elderly

From Clinical Nutrition in Gastrointestinal Disease
More »
Resource Centers
Heart in Diabetes

Heart in Diabetes

Meeting News

VIDEO: Cimzia data provides ‘reassuring’ pregnancy outcomes for rheumatic disease, IBD

June 16, 2018
More »